EM2306G "Mind the Gap, Stepping on a Bridge to Life" (IM GR-060223)
Purpose and Overview
Improvements in cancer diagnosis and therapy continue to increase the population of long-term survivors. Some patients transition through very dangerous moments during their oncological therapy. Cardiovascular health is crucial for completing oncological therapy plans as well as for thriving during life after cancer. At the intersection between cardiovascular medicine and oncology, cardio-oncology is aiming to minimize cardiovascular risks and allow to maximize oncological therapy delivery for improving overall outcomes in cancer survivors. Therefore, in this presentation I will provide an update on the cardiotoxic risks of current oncological therapies, strategies to mitigate them and avenues to increase equitable healthcare for long term cancer survivors.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Identify intersections between cancer, current anti-cancer therapies and the cardiovascular system.
- Recognize emerging guideline-based recommendations for assessment and monitoring of patients at risk for short-term and long-term cardiovascular effects of anti-cancer therapies.
- Describe the implicit disparity of patients at the crossroad between cancer and cardiovascular health, and the importance of social determinants of health in this setting.
Vlad Zaha, M.D., Ph.D.
Associate Professor of Internal Medicine
Division of Cardiology
- 1.00 AMA